POPULARITY
2 episodes with early identification
2 episodes with early identification
7 episodes with early identification
2 episodes with early identification
2 episodes with early identification
3 episodes with early identification
3 episodes with early identification
3 episodes with early identification
2 episodes with early identification
About this episode: Diagnoses of autism are on the rise, but is this the result of more children being affected by the condition, or is more of a consequence of broader criteria and more screening? In this episode: a look at a new study about the number of children diagnosed with autism and what this research shows—and doesn't show. Guest: Dr. Christine Ladd-Acosta is an autism researcher and vice-director of the Wendy Klag Center for Autism and Developmental Disabilities. She is the lead Maryland investigator on a national study about the rate of autism. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Prevalence and Early Identification of Autism Spectrum Disorder Among Children Aged 4 and 8 Years - Autism and Developmental Disabilities Monitoring Network, 16 Sites, United States 2022—CDC's MMWR RFK Jr.'s autism study to amass medical records of many Americans—CBS News The NIH-Funded Autism Study Hoping to Pinpoint Gene-Environmental Interplay—Public Health On Call (March 2025) Vaccines Don't Cause Autism. Why Do Some People Think They Do?—Hopkins Bloomberg Public Health Discovering How Environment Affects Autism—Hopkins Bloomberg Public Health Magazine (2023) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @PublicHealthPod on Bluesky @JohnsHopkinsSPH on Instagram @JohnsHopkinsSPH on Facebook @PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
In this special episode on Early Identification and Delay of Type 1 Diabetes, Dr. Neil Skolnik this emerging area with Dr. Jay Shubrook. This special episode is supported by an independent educational grant from Sanofi. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Jay Shubrook, D.O. - Professor and Director of Diabetes Services, Touro University. Past Chair, The American Diabetes Association Primary Care Advisory Group, Past Chair of the American College of Diabetology. Selected References and Resources referred to the in the Podcast: Webinar Registration (Apr 28, 2025 10:00 AM): Early Detection Saves Lives: Implementing Type 1 Diabetes Screening in Pediatric and Primary Care References: Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetes Care 2024;47(8):1276–1298 An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med 2019;381:603-613 Resources for Auto-antibody Testing: Type 1 Diabetes TrialNet Centers of Excellence Locations Type 1 Risk test Trialnet
In today's climate, ensuring safety in educational settings is paramount. Join us for "Prevent Harm" a crucial installment in the "Path to Safer Schools" series. This podcast brings together a panel of esteemed experts, from diverse backgrounds such as education, law enforcement, mental health, and technology. Together, they will explore innovative strategies and community engagement tactics to safeguard our students.Panel Discussion Overview:The "Prevent Harm" podcast is tailored to equip educators, administrators, parents, and policymakers with actionable insights to cultivate safer school environments. Our panel will engage in dynamic discussions covering topics such as:Early Identification of Risks: Proactive approaches to identify and mitigate potential threats, leveraging behavioral assessments and social media monitoring.Building a Culture of Safety: Strategies to foster a secure and supportive school culture where reporting concerns is encouraged.Innovative Safety Technologies: Exploration of cutting-edge technologies, from advanced security systems to anonymous reporting apps, to bolster school safety.Mental Health and Well-being: test technological advancements that can enhance school safety, from advanced security systems to apps that facilitate anonymous reporting.Mental Health and Well-being: Addressing the critical importance of mental health services in schools as a preventative measure, including counseling, peer support programs, and staff training.Community and Law Enforcement Collaboration: Effective models for collaboration between schools, local communities, and law enforcement agencies to ensure a coordinated response to safety concerns.Policy and Legislative Considerations: Discussion on current and proposed policies impacting school safety and how attendees can advocate for positive change.Speakers Kevin Eberle, EdDCOO Buffalo Public Schools, Ret.·Edingenuity, LLCDr. Kevin Eberle brings over 27 years of experience as a building administrator and former police officer to the field of education consulting, focusing on safety and culture change. As a retired school principal and COO of Buffalo Public Schools, he has also served as a teacher, counselor, and assistant principal. Dr. Eberle's multidisciplinary approach emphasizes trauma-informed care, restorative practices, and positive staff development with mindfulness techniques, demonstrating how these strategies can transform a school's culture and fabric. He is an associate with Zeal Education Group and serves on the boards of the Police Athletic League, Family Justice Center, OLV Humane Service, and Zero Now. John BullwinkelRetired US Secret ServiceJohn Bullwinkel is an accomplished Secret Service Special Agent with over 20 years of experience in national and global security leadership, focusing on personnel and facilities in the nation's capital. Transitioning to a Threat Manager role in the public sector, John brings extensive expertise in high-level security assurance and threat management. His skills encompass security system assessments, risk mitigation, high-level security operations, executive-level protection, tactical team operations, logistics, event security planning, and team leadership. Known for building valuable relationships, John excels in collaborating with stakeholders, management, team members, vendors, and clients at all organizational levels. Brian KatzSafer School SolutionsBrian Katz most recently served as the Chief Safety and Security Officer for the Broward County Public School District, the nation's 6th largest school district. With over 20 years of experience in physical security, investigations, and executive protection, he has provided security consulting for Fortune 500 companies and other unique clients.At Google, Mr. Katz was the Director of Personnel Protective Services, where he built Google's Global Security Investigations and Intelligence teams from a single person to an industry-leading strategic global organization. He developed the Executive Protection Group, Intelligence Group, and the Global Security Operations Center, managing the company's Aviation program and responding to emergent threats worldwide.Following the Marjory Stoneman Douglas High School tragedy in 2018, Broward County School District created a Division of Safety, Security, and Emergency Preparedness as a Cabinet-level Chief position. Mr. Katz was selected to fill this role in February 2019 after a national search. In this position, Mr. Katz designed the new Division from the ground up, centralizing all safety and security functions, doubling the number of security staff, and creating layers of safety and security accountability. He also developed a comprehensive safety and security training framework, rolling out these initiatives district-wide.
This week on the podcast Monique interviews the incredible Associate Professor Josephine Barbaro. Josie is a late identified Autistic ADHDer. She is a Principal Research Fellow and Psychologist at the Olga Tennison Autism Research Centre, La Trobe University, Melbourne. She is the Research Director of Identification and Diagnosis of Autism, and Clinical Director of the Victorian Early Assessment Clinic, providing neuro-affirming, transdisciplinary assessments for neurodivergence in children under 3 years. Josie's research interests are in the early identification and diagnosis of Autism, family health and well-being following a diagnosis, and Neurodiversity Affirming research and practice. In this episode Monique and Josie cover: Josie's path to understanding her own neurodivergence. The heritability of neurodivergence and the importance of taking a whole-family approach to supporting neurodivergent kids. Josie's work on early identification of Autism and the development of the SACS early identification screening tool and the ASDectect app. Josie's research and work into closing the gender gap in early diagnosis of Autism. Why early identification is so important and addressing concerns parents can have around ‘labelling'. How to share a diagnosis of Autism with your child. Debunking the myths around overdiagnosis of Autism. Things we mentioned: The Victorian Early Assessment Clinic. The SACS early identification screening tool training The ASDectect app Conversation article co-written by Josie and Marie Camin on talking to your child about their diagnosis. Conversation article co-written by Josie and Dr Nancy Sadka debunking the myth around overdiagnosis of Autism. Books to use as a conversation starter to introduce neurodivergence to a child include The Brain Forest and The Rainbow Brain, both by Sandyha Menon, and Round World Square Me by Chelsea Luker. You can contact Josie via email at veac@latrobe.edu.au or find her on her socials here. Want polished copies of our episodes in beautiful and readable pdf article format? Grab them here. Enjoyed the episode and want to support us further? Join our Patreon community! Patreon subscribers receive basic episode transcripts from Season 4 onwards, access to a monthly live zoom hang out, 50% off our episode articles, plus bonus monthly content (depending on subscription tier). Check out our Patreon page to support us, as we aim to make quality mental health care information accessible to everyone: www.patreon.com/ndwomanpod. See omnystudio.com/listener for privacy information.
Dr. Halley Alexander talks about the use of machine learning models to identify candidates for resective epilepsy surgery earlier in the disease course. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000208048
Important insights from research are illuminating secrets of Chronic Pain in Children.This episode looks at research into the complexities of chronic pain among children. Dr. Lenz discusses the growing understanding that chronic pain often arises from how the central nervous system interprets sensory inputs. The episode highlights the importance of early detection and treatment of chronic pain in altering its lifelong course. Also, it emphasizes that neuroimaging studies have found specific correlations in the brain with chronic pain, but more research is needed. 00:00 Introduction to Chronic Pain in Young People01:00 Meet Your Host, Dr. Michael Lenz01:44 The Struggles of Chronic Pain Patients02:55 The Prevalence of Chronic Pain in Children03:22 The Role of Pediatricians in Chronic Pain Management03:51 Understanding Nociplastic Pain05:10 The Importance of Early Identification and Treatment05:56 The Adolescent Brain and Cognitive Development Study09:58 The Role of Genetics in Chronic Pain12:40 The Future of Chronic Pain Treatment13:18 Understanding the Risk Factors for Chronic Pain13:46 Is there a Role of Functional MRI in Chronic Pain Diagnosis19:09 The Impact of Sex Differences on Chronic Pain20:39 Conclusion: The Future of Chronic Pain Research22:15 Final Thoughts Support the showA Fibromyalgia Starter Pack, which is a great companion to the book Conquering Your Fibromyalgia, is now available. Dr. Michael Lenz practices general pediatrics and internal medicine primary care, seeing patients from infants through adults. In addition, he also will see patients with fibromyalgia and related problems and patients interested in lifestyle medicine and clinical lipidology. To learn more, go to ConquringYourFibromyalgia.com. Remember that while Dr. Lenz is a medical doctor, he is not your doctor. All of your signs and symptoms should be discussed with your own physician. He aims to weave the best of conventional medicine with lifestyle medicine to help people with chronic health conditions live their best lives possible. Dr. Lenz hopes that the podcast, book, blog, and website serve as a trusted resource and starting point on your journey of learning to live better with fibromyalgia and related illnesses.
In this episode of the Authentic Advisor, James Mason interviews Peter Lucas from Kestrel Solutions about turning around underperforming businesses. They discuss the challenges faced by business owners and managers, the early warning signs of a troubled business, and the use of technology for early identification. Peter shares his approach to starting the turnaround process, including conducting waste audits and involving the team. He also shares a case study of a successful turnaround in the timber windows and doors industry. The episode concludes with Peter offering final tips for advisors seeking to help their clients in similar situations. Takeaways Cash flow is the number one factor to focus on in turning around a business. Advisors should have knowledge of insolvency laws and directors' duties. Implementing waste audits and involving the team can help identify areas of improvement. Constant involvement and evolution, along with constructive guidance, can prevent businesses from slipping back into bad habits. Advisors should consider requesting upfront payment and avoiding time-based billing to maintain trust and accessibility. Chapters 01:10 Introduction and Background 03:20 Challenges for Business Owners and Managers 05:45 Early Warning Signs of a Troubled Business 10:22 Using Technology for Early Identification 12:23 Starting the Turnaround Process 16:00 Waste Audits and Involving the Team 21:01 Case Study 22:43 Constant Involvement and Evolution 25:58 Final Tips for Advisors
With this concise episode, expert faculty bring you insights from the evolving area of Alzheimer disease diagnosis, including strategies for improving identification of cognitive decline and incorporating evidence-based tools in screening. Discover the impact of advanced neuroimaging and fluid markers, empowered by recent FDA approvals of anti-amyloid therapies. Come away with actionable knowledge to boost your role in cognitive health.
Jennifer Bain, MD, PhD, is an assistant professor of neurology and pediatrics at Columbia University Medical Center. Dr. Bain completed both an M.D. and PhD. as well as general pediatrics residency at Rutgers – New Jersey Medical School in New Jersey. She then trained in Child Neurology at New York Presbyterian – Columbia University Medical Center in New York City and is a board-certified neurologist with special certification in Child Neurology seeing both inpatient and outpatient pediatric neurology patients. Her clinic focuses on diagnosis and management of autism, cerebral palsy and neurodevelopmental disorders in addition to genetic disorders associated with such conditions. Her early research career focused on spinal cord and brain development after injuries such as spinal cord injury and perinatal hypoxic ischemic encephalopathy. During her residency training, her clinical research focused on studying autonomic dysfunction in children with autism spectrum disorders and neurological complications during extracorporeal membrane oxygenation. She currently works as a physician scientist at Columbia University specializing in general pediatric neurology with expertise in development, behavioral neurology, autism and cerebral palsy. Her clinical research has focused on studying the genetics of neurodevelopmental disorders including autism and cerebral palsy. The genes she has worked closely on include HNRNPH2 and related disorders, GRIN disorders, KIF1A. She is interested in understanding clinically meaningful measures in families affected by neurodevelopmental disorders and measuring longitudinal trajectories in such disorders. She has been working closely with several patient advocacy groups, researchers, and Simons Searchlight to continuously move forward in the understanding of the developing and aging brain. JOWMA Podcast | Learn The Signs, Act Early: Dr. Lisa Shulman on the Early Identification and Treatment of Autism https://anchor.fm/jowma/episodes/Learn-The-Signs--Act-Early-Dr--Lisa-Shulman-on-the-Early-Identification-and-Treatment-of-Autism-e22noo5 JOWMA Podcast | All Brains Belong with Dr. Mel Houser, MD https://anchor.fm/jowma/episodes/All-Brains-Belong-with-Dr--Mel-Houser--MD-e1t1rjn JOWMA Podcast | Uniquely Human with Dr. Barry Prizant, PhD, CCC-SLP https://anchor.fm/jowma/episodes/Uniquely-Human-with-Dr--Barry-Prizant--PhD--CCC-SLP-e1ogbg2 JOWMA Podcast | It Takes A Village- Advocating for Inclusion with Esti Schiffmiller https://anchor.fm/jowma/episodes/It-Takes-A-Village--Advocating-for-Inclusion-with-Esti-Schiffmiller-e1klr32 JOWMA Podcast | On The Spectrum: All About Autism With Dr. Devorah Segal https://anchor.fm/jowma/episodes/On-The-Spectrum-All-About-Autism-With-Dr--Devorah-Segal-e1eqv4u JOWMA Podcast | "If you've met one individual with autism, you've met one individual with autism." The Journey of Dr. Stephen Shore, Autistic Professor of Special Education https://anchor.fm/jowma/episodes/If-youve-met-one-individual-with-autism--youve-met-one-individual-with-autism--The-Journey-of-Dr--Stephen-Shore--Autistic-Professor-of-Special-Education-e1eqv4k_______________________________________________________ Become a JOWMA Member! www.jowma.org Follow us on Instagram! www.instagram.com/JOWMA_org Follow us on Twitter! www.twitter.com/JOWMA_med Follow us on Facebook! https://www.facebook.com/JOWMAorg/ Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e
https://swiy.co/WhatAreYourThoughtsIn a heartfelt conversation, host Dr. Lia Gaggino is joined by Julius Towers, a remarkable father and advocate who opens up about his personal journey raising twins with autism. From highlighting the importance of early testing to addressing equity and stigma, this episode sheds light on the realities faced by families of children with special needs. It's clear that the journey of parenting a child with autism is filled with challenges and uncertainties. Pediatricians have a crucial role to play in supporting families dealing with autism. By providing clear and compassionate communication, offering guidance and resources, and advocating for their patients, they can make a lasting impact on the lives of these children and their families. Together, we can build a world that celebrates neurodiversity. Let us remember that every child deserves access to early intervention and support, and it is up to each one of us to ensure that no child with autism is left behind. [00:33 -19:47] Early Identification is Key for Child DevelopmentEarly identification allows for timely access to necessary resources and therapies.Parents should be encouraged to observe their child's developmental milestones and seek professional guidance if any concerns arise.Early intervention services can significantly improve a child's overall development and future outcomes.Building awareness about the importance of early identification can lead to better support systems for children and their families.[19:48 - 30:02] Challenges Faced by Minoritized Populations Underdiagnosis issues in minoritized populationsReasons for missed or dismissed diagnosesImpact of underdiagnosis on health outcomesAddressing disparities in healthcare through awareness and education[30:03 - 43:26] Managing overwhelming emotionsAcknowledge the emotional whirlwind that comes with seeking servicesTry not to get caught up in thinking too far ahead into the futureEstablish some emotional boundaries to prevent feeling overwhelmedSeek out counseling or support groups to help navigate the journey[43:26 - 59:24] Steps for Early Diagnosis and Support Screen for developmental delays or disorders in children.Provide prompt referral to early intervention programs and specialized services.Educate parents and caregivers about available resources and support networks.Continuously monitor and track progress to ensure appropriate interventions.[59:25 - 1:05:48] Closing segment TakeawayYou can reach Julius TowersEmail: j.y.towers@gmail.comLinkedIn: www.linkedin.com/in/juliustowersLinks to resources mentioned on the showAutism Speaks Parent Guide: https://www.autismspeaks.org/tool-kit/parents-guide-autismCDC ADDM Network Community Report : https://www.cdc.gov/ncbddd/autism/addm-community-report/index.htmlAutistic Self Advocacy Network parent guide:
The Windward Institute and The Windward School are putting "Dyslexia in Focus" in recognition of Dyslexia Awareness Month. This month on READ, you will hear from four past READ experts on insights specific to dyslexia and topics related to screening and identification, education and intervention, and advocacy. This "Dyslexia in Focus" READ bookmark features Dr. Hugh Catts from Episode 18. In this bookmark, you will learn more about:markers of dyslexiacurrent research examining the risks of reading disabilitiesimplications for screening and interventionYou can listen to the full conversation with Dr. Catts, on Episode 18, "Early Identification and Intervention of Reading Disabilities."Stay up to date with the READ Podcast and "Dyslexia in Focus" during Dyslexia Awareness Month on YouTube, Twitter @TheWindwardInst, Instagram @thewindwardinstitute, or Facebook. Do you have questions for future topics and speakers? E-mail us at info@readpodcast.org.Until next time, READers!
In this episode of the Exceptional Girls podcast, you're invited to listen in as I talk with Dr. Linda Silverman, a well-known and respected expert in giftedness in both girls and adult women. Dr. Silverman shares invaluable information for parents and caregivers of girls who are gifted, or who they suspect may be. You'll come away with a deeper understanding of:What giftedness really is and how it presents in girls differently than boysWhat you really need to know about IQ testsWhy gifted and neurodivergent girls can easily slip through the cracksThe critical clues that your daughter may be gifted or twice exceptionalWhy early identification of neurodivergence in girls is so importantDr. Silverman also shares helpful insights about gifted adult women at the end that you won't want to miss.About the Exceptional Girls podcastIf you know and care deeply about a girl who learns, thinks, and experiences the world differently, I invite you to journey with me as we learn how we as parents, adults, and role models can help her understand, self-advocate, accept, and love herself — just as she is.To learn more, visit our website at: www.exceptionalgirlspodcast.com.
The burden of disease is high and there is a huge number of patients undiagnosed The outcomes are terrible, 1 to 5 years worse than cancers The biggest opportunity is in primary care for GPs to try and identify these patients. The easiest way is to listen to the heart and any abnormality, the patient should be referred to the heart team or cardiologist Host: Dr David Lim | Total Time: 27 mins Guests: A/Prof Kaleab Asrress, Interventional Cardiologist Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next oneSee omnystudio.com/listener for privacy information.
evolve with dr. tay | real conversations designed for autism parents
answering YOUR questions on today's episode!Q: my child is 13 months old and has developmental delays. I'm concerned about autism. how do I know if it's autism or a developmental delay? my pediatrician says they won't start screening for autism until 18 months of age.A: Dr. Tay unpacks the American Academy of Pediatrics guidelines for autism screening and breaks down the science to address this question. in short, autism can be diagnosed accurately (for some but not all children) beginning at 14 months of age. practical next steps are provided, with encouragement to act early so your child can get necessary supports as soon as possible.RESOURCES⚡️ the research study referenced in today's episode: https://pubmed.ncbi.nlm.nih.gov/31034004/ ⚡️ join the Evolve Facebook community to participate in the episode Q+As >> facebook.com/groups/evolveautism⚡️ learn from me and submit your questions [could be featured on a future episode] >>Instagram @the.dr.tayTikTok @the.dr.tayLinkedIn @the-dr-tay⚡️ want to learn more about Dr. Tay's Whole Family Approachᵀᴹ and current services offered? schedule a free consult call here or email admin@drtaylorday.com if you have questions.DISCLAIMER >> anything shared on this podcast should not be considered clinical advice, and you should consult with your team of medical, mental health, and developmental providers if you need support.
This episode from the 2022 Midyear Clinical Meeting discusses the current methodologies used in identifying COVID-19 and how pharmacists can evaluate commercial genetic tests used in identifying respiratory pathogens and antibiotic-resistant markers. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Dr. Lisa Heidi Shulman M.D. is a Professor Pediatrics at the Albert Einstein College of Medicine at the Children's Hospital at Montefiore. A Developmental Pediatrician with over 30 years at the institution, Dr. Shulman is the Director of Autism Services, and interim Director of the Rose F. Kennedy Children's Evaluation & Rehabilitation Center at Montefiore. She also directs the Leadership Education in Neurodevelopmental and related Disabilities grant through Maternal and Child Health Bureau.Dr. Shulman currently serves on the Autism Sub-committee of the National AAP Council on Children with Disabilities, serving on the Education, Learn the Signs Act Early, and Payer Advocacy Committees. From 2016-2019 she served as the Centers for Disease Control Act Early Ambassador to New York State.A graduate of Brown University and University of Pennsylvania School of Medicine. She is board-certified in Pediatrics and Developmental and Behavioral Pediatrics. Her clinical and research interests include: early identification of autism, overcoming healthcare disparities in autism diagnosis, and follow up of children with an early diagnosis of Autism. _______________________________________________________ Related Episodes: On the Spectrum: All About Autism with Dr. Devorah Segal | JOWMA Podcast https://podcasters.spotify.com/pod/show/jowma/episodes/On-The-Spectrum-All-About-Autism-With-Dr--Devorah-Segal-e1eqv4u Uniquely Human with Dr. Barry Prizant, PhD, CCC-SLP | JOWMA Podcast https://open.spotify.com/episode/2micH8mmCnbAffltumUVUS?si=bf8695c683444b56 "If you've met one individual with autism, you've met one individual with autism." The Journey of Dr. Stephen Shore, Autistic Professor of Special Education | JOWMA Podcast https://spotifyanchor-web.app.link/e/w6iz8ynG9yb Ask The Expert: ADHD and Autism, Q &A with Developmental-Behavioral Pediatrician Dr. Amir Miodovnik | JOWMA Podcast https://spotifyanchor-web.app.link/e/CTzR1UxG9yb _______________________________________________________ Become a JOWMA Member! www.jowma.org Follow us on Instagram! www.instagram.com/JOWMA_org Follow us on Twitter! www.twitter.com/JOWMA_med Follow us on Facebook! https://www.facebook.com/JOWMAorg/ Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e
As part of our ongoing dialogue around clinical care pathways and the complex of metabolic diseases, SurfingNASH dedicates a session to focus on the key relationship and interplay between endocrinology and hepatology. This topic rings familiar in the Rising Tide series, our podcast for frontline education, where Ken Cusi often notes the need for endocrinologists to become comfortable diagnosing Fatty Liver disease (and prescribing pioglitazone) and for hepatologists to become more comfortable prescribing GLP-1s. To expand on these critical ideas with the SurfingNASH community, Jörn Schattenberg, Louise Campbell and Roger Green are joined by Cyrielle Caussy, Professor of Nutrition and Endocrinologist-Diabetologist at Lyon 1 University and Lyon South Hospital, Hospices Civils de Lyon (France). Cyrielle is an expert in the clinical care of metabolic disease, including type 2 diabetes, obesity and NAFLD, and she is leading a clinical and research program focused on metabolic liver disease at the Lyon Hepatology Institute. 02:14 Introducing Cyrielle Caussy and Her Professional BackgroundNew to the podcast, Cyrielle takes a moment to outline her career trajectory and how she became interested in Fatty Liver disease and its growing area of overlap within the wider scope of medical care.08:42 Educating Endocrinologists on the Power of NITs Developed in HepatologyFrom here, Roger describes overarching questions that the episode aims to cover:What does the interaction between endocrinologists and hepatologists look like from their relative perspectives? In practical terms, how does each approach care pathways, referrals and collaboration? What about either speciality would be key for the other to learn more about, develop and integrate? Jörn comments on the value of deploying the NITs developed by the hepatology community to endocrinology clinics. He notes the practical barriers which could hinder uptake and utilization. Among other insights, Cyrielle underscores the importance behind raising awareness among our endocrinology colleagues that patients in routine screening are regularly diagnosed with advanced fibrosis and cirrhosis in the absence of symptoms.14:32 The Importance of Early Identification in At-Risk Populations and Implementing GuidelinesRoger notes that around 50% of all cirrhosis is diagnosed for the first time during a decompensation event at the emergency department. He asks whether the endocrinology clinic is the right place to identify patients much sooner. Jörn suggests the answer is yes considering that we know the risk and prevalence of advanced fibrosis in this population to be high. The group goes on to discuss requesting and receiving lab results in their respective different systems.25:55 Discussing the Patient Perspective in Endocrinology ClinicsLouise asks how do patients respond when informed of fibrosis or other liver related conditions in the endocrinology clinic setting. 33:40 Biomarkers, Holistic Metabolic Assessment and PathwaysThe groups discusses takeaways from various studies on the interrelatedness of concurrent metabolic conditions and the influence of liver health.40:57 Calling All Parties to Invest in Fighting Fatty LiverIf you enjoy the episode, have questions or interest around endocrinology and Fatty Liver disease, we kindly ask that you submit reviews wherever you download the discourse. Alternatively, you can write to us directly at questions@SurfingNASH.com.Stay Safe and Surf On!
In this episode of CUBIST, Amanda and Don discuss the article, "Risk Factors for high symptom burden three months after traumatic brain injury and implications for clinical trial design: A TRACK-TBI study” by Nancy Temkin and colleagues, published in the Journal of Neurotrauma in June of 2022. Article Citation: Temkin, N., Machamer, J., Dikmen, S., Nelson, L. D., Barber, J., Hwang, P. H., Boase, K., Stein, M. B., Sun, X., Giacino, J., McCrea, M. A., Taylor, S. R., Jain, S., Manley, G., & TRACK-TBI Investigators (2022). Risk Factors for High Symptom Burden Three Months after Traumatic Brain Injury and Implications for Clinical Trial Design: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study. Journal of Neurotrauma, 39(21-22), 1524–1532. Article LINK: https://pubmed.ncbi.nlm.nih.gov/35754333/ CUBIST is a podcast for healthcare providers produced by the Traumatic Brain Injury Center of Excellence. We discuss the latest research on traumatic brain injury (TBI) most relevant to patient care. For more about TBI, including clinical tools, go to www.health.mil/TBICoE or email us at dha.TBICoEinfo@health.mil. The views, opinions, and/or findings in this podcast are those of the host and subject matter experts. They should not be construed as an official Department of Defense position, policy, or decision unless designated by other official documentation. Our theme song is “Upbeat-Corporate' by WhiteCat, available and was used according to the Creative Commons Attribution-Noncommercial 4.0 license.
In this episode of CUBIST, Amanda and Don discuss the article, "Risk Factors for high symptom burden three months after traumatic brain Injury and implications for clinical trial design: A TRACK-TBI study” by Nancy Temkin and colleagues published in the Journal of Neurotrauma in June of 2022. Article Citation: Temkin, N., Machamer, J., Dikmen, S., Nelson, L. D., Barber, J., Hwang, P. H., Boase, K., Stein, M. B., Sun, X., Giacino, J., McCrea, M. A., Taylor, S. R., Jain, S., Manley, G., & TRACK-TBI Investigators (2022). Risk Factors for High Symptom Burden Three Months after Traumatic Brain Injury and Implications for Clinical Trial Design: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study. Journal of Neurotrauma, 39(21-22), 1524–1532. Article LINK: https://pubmed.ncbi.nlm.nih.gov/35754333/ CUBIST is a podcast for healthcare providers produced by the Traumatic Brain Injury Center of Excellence. We discuss the latest research on traumatic brain injury (TBI) most relevant to patient care. For more about TBI, including clinical tools, go to www.health.mil/TBICoE or email us at dha.TBICoEinfo@health.mil. The views, opinions, and/or findings in this podcast are those of the host and subject matter experts. They should not be construed as an official Department of Defense position, policy, or decision unless designated by other official documentation. Our theme song is “Upbeat-Corporate' by WhiteCat, available and was used according to the Creative Commons Attribution-Noncommercial 4.0 license.
In this episode, Dr. Vincent Alfonso, psychologist and Professor in the School of Education at Gonzaga University, discusses why early, accurate identification is so important, what developmentally-based evaluations typically entail, how early a child can be identified with an LD, and why universal screeners for learning disabilities are so essential.
Sonam Kiwalkar, MD, Vancouver Clinic CME Credit Available for all Providence Providers In order to claim CME credit, please click on the following link: https://forms.office.com/r/FwhWwm6F4W (or copy & paste into your browser) Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Planning Committee & Faculty Disclosure: The Planning Committee and faculty have no relevant financial relationships with ineligible companies interests to disclose. Original Date: September 20, 2022 End Date: September 20, 2023
Sonam Kiwalkar, MD, Vancouver Clinic CME Credit Available for all Providence Providers In order to claim CME credit, please click on the following link: https://forms.office.com/r/FwhWwm6F4W (or copy & paste into your browser) Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Planning Committee & Faculty Disclosure: The Planning Committee and faculty have no relevant financial relationships with ineligible companies interests to disclose. Original Date: September 20, 2022 End Date: September 20, 2023
To get an edge in your prep career, you need to learn about the 2/10ths speed and agility and the man behind it, DeWayne Brown. In this interview, I deep dive into what makes his training approach so innovative and what's the secret to his track record for success. If you want to understand the nuances of the early identification process, specialized training and the competitive environment are needed.This episode is for you."You get what you Earn."Just a few Pros that have gone through his program. Aaron Donald, Los Angeles Rams Jaquan Brisker, Chicago Bears Miles Sanders, Philadelphia EaglesSky Moore, Kansas City Chiefs Does your son dream of playing college football at the highest level?www.ligbluechip.comConnect with Justin and the Blue Chip Academy on Social Media:https://linktr.ee/JKingLIG
CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases
Please visit answersincme.com/TAC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in infectious diseases discusses the early identification and treatment of patients with COVID-19 who are at a higher risk of progression to severe illness. Upon completion of this activity, participants should be better able to: Identify nonhospitalized patients with COVID-19 who have risk factors for progression to severe illness; Describe national guideline recommendations for the therapeutic management of nonhospitalized patients with COVID-19 who are at risk for progression to severe illness; and Outline a personalized management approach to enhance outcomes for nonhospitalized patients who are diagnosed with COVID-19 and are at risk for progression to severe illness.
Please visit answersincme.com/TAC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in infectious diseases discusses the early identification and treatment of patients with COVID-19 who are at a higher risk of progression to severe illness. Upon completion of this activity, participants should be better able to: Identify nonhospitalized patients with COVID-19 who have risk factors for progression to severe illness; Describe national guideline recommendations for the therapeutic management of nonhospitalized patients with COVID-19 who are at risk for progression to severe illness; and Outline a personalized management approach to enhance outcomes for nonhospitalized patients who are diagnosed with COVID-19 and are at risk for progression to severe illness.
Central nervous system (CNS) tumors account for a quarter of all cancers in children aged 1 to 19 years. Nearly 70% of CNS tumors can be effectively treated, but early detection is critical to allow for the best possible treatments and outcomes. Too often, CNS tumors are initially misdiagnosed as more common pediatric conditions such as migraine, gastroenteritis or other psychologic and behavioral problems. In this episode, we discuss the classic signs and presentations of CNS tumors to support early detection. Our guest for today's episode is Dr. Green. Dr. Green is part of the Center for Cancer and Blood Disorders Team at Children's Hospital Colorado and is Assistant Professor of Pediatrics, Hematology/Oncology/and Bone Marrow Transplantation at the University of Colorado School of Medicine.
Sepsis impacts over 1.7 million Americans each year resulting in over 270,000 deaths (a death every 2 minutes). According to a Centers for Disease Control and Prevention (CDC) study, as many as 87% of sepsis cases begin outside of the hospital, so early identification and treatment in the post-acute setting is key to reducing morbidity and mortality in this population. Healthcare personnel in skilled nursing facilities play a significant role in early identification and treatment of sepsis. This presentation will overview sepsis, its pathophysiology, signs and symptoms and treatment within the context of skilled nursing and long term care (LTC). It will outline an early identification and treatment process for sepsis and how to incorporate it into usual work processes including communication strategies to providers that focus on action. Strategies for patient and family education will also be reviewed. To watch the lecture, and learn more about the speaker, please visit https://www.continulus.com
Welcome to a new Hot Topics Podcast from NB Medical with Dr Neal Tucker. It's the summer holidays! We hope a little pressure is off at your practices and you might even get a break yourself. In this podcast, we discuss the latest news including whether GPs simply aren't working hard enough and debate a £10 charge for DNAs.In research, we look at new data from JAMA suggesting patients are at increased risk of MI shortly after a flare of gout, a fantastic paper in the BJGP presenting data showing how it may be possible to improve early identification of colorectal cancer based on common symptoms and blood results, and more from the BJGP with qualitative research exploring the barriers to shared decision making in patients with multimorbidity. ReferencesJAMA Gout and acute CVDBJGP Early Identification of CRCBJGP Shared decision making and multimorbidity
In this podcast, Jill Zwicker discusses her papers 'Early intervention for children with/at risk of developmental coordination disorder: a scoping review' and 'Early identification of children with/at risk of developmental coordination disorder: a scoping review'. The papers are available to read here: https://onlinelibrary.wiley.com/doi/full/10.1111/dmcn.14803 https://onlinelibrary.wiley.com/doi/10.1111/dmcn.14804 Subscribe to our channel for more: https://bit.ly/2ONCYiC ___ Listen to all our episodes: https://bit.ly/2yPFgTC __ DMCN Journal: Developmental Medicine & Child Neurology (DMCN) has defined the field of paediatric neurology and childhood-onset neurodisability for over 60 years. DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families. DMCN Journal - https://onlinelibrary.wiley.com/journal/14698749 ___ Watch DMCN videos on our YouTube channel: https://bit.ly/2ONCYiC Find us on Twitter! @mackeithpress - https://twitter.com/mackeithpress
CME credits: 0.50 Valid until: 19-05-2023 Claim your CME credit at https://reachmd.com/programs/cme/qad-addressing-challenges-in-alzheimers-disease-from-early-identification-to-new-treatment-considerations/13485/ Alzheimer's Disease (AD) is a progressive disease that presents challenges when it comes to the early diagnosis and treatment of patients. That's why this two-part series will help answer your specific questions while providing expert insights into these challenges. In this first activity, a panel of esteemed faculty will examine the case of a patient who was diagnosed early with mild cognitive impairment (MCI) due to AD, prior to dementia. Using this patient case, faculty will delve into both the importance of early identification of AD and how to detect it early. The panel will then discuss the pathobiology of AD and potential treatments in development to target this pathology. Finally, the panel will explore current treatment options, including the appropriate use of anti-amyloid monoclonal antibody (mAb) treatment. If you would like to view the second part of this series, please click here.
CME credits: 0.50 Valid until: 19-05-2023 Claim your CME credit at https://reachmd.com/programs/cme/qad-addressing-challenges-in-alzheimers-disease-from-early-identification-to-new-treatment-considerations/13485/ Alzheimer's Disease (AD) is a progressive disease that presents challenges when it comes to the early diagnosis and treatment of patients. That's why this two-part series will help answer your specific questions while providing expert insights into these challenges. In this first activity, a panel of esteemed faculty will examine the case of a patient who was diagnosed early with mild cognitive impairment (MCI) due to AD, prior to dementia. Using this patient case, faculty will delve into both the importance of early identification of AD and how to detect it early. The panel will then discuss the pathobiology of AD and potential treatments in development to target this pathology. Finally, the panel will explore current treatment options, including the appropriate use of anti-amyloid monoclonal antibody (mAb) treatment. Throughout this activity, we will gather questions from clinicians like you who care for patients living with dementia, and then in part two of this series, we will answer some of the questions generated from this first activity.
Elevated intracranial pressure is a life-threatening cancer complication, but oncology nurses can take steps to prevent and recognize it in their patients. ONS member Mary Elizabeth Davis, DNP, RN, AOCNS®, clinical nurse specialist at Memorial Sloan Kettering Cancer Center in New York, NY, and member of the New York City ONS Chapter, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about the latest nursing strategies for increased intracranial pressure, a situation that can occur with a brain tumor, abscess, infection, or other conditions that increases or obstructs cerebrospinal fluid or blood flow in the brain. This episode is part of a series about oncologic emergencies; the previous episodes are linked in the episode notes. You can also earn free NCPD contact hours by completing the evaluation linked in the episode notes. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by April 15, 2024. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode: Complete this evaluation for free NCPD. Previous Oncology Nursing Podcastepisodes on oncologic emergencies Oncology Nursing Forum article: Early Identification of Intracranial Hemorrhage Using a Predictive Nomogram ONS book: Understanding and Managing Oncologic Emergencies: A Resource for Nurses(third edition) ONS course: Essentials in Oncologic Emergencies for the Advanced Practice Provider ONS course: Oncologic Emergencies ONS course: Treatment and Symptom Management—Oncology RN ONS Huddle Cards™ American Association of Neuroscience Nurses American Brain Tumor Association To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Age-related hearing loss is a common problem in adults, and it might be starting earlier than we think. Courtney Coburn Glavin, a PhD candidate, at Northwestern University sits down with Dr. Brian Taylor to review her research using DPOAEs to identify hearing loss of early onset in young adults and the clinical implications of her work. They also discuss the limitations of the pure tone audiogram and intervention strategies for people with subclinical forms of hearing loss. Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter: https://www.linkedin.com/company/this-week-in-hearing/ https://twitter.com/WeekinHearing
Central nervous system (CNS) tumors account for a quarter of all cancers in children aged 1 to 19 years. Nearly 70% of CNS tumors can be effectively treated, but early detection is critical to allow for the best possible treatments and outcomes. Too often, CNS tumors are initially misdiagnosed as more common pediatric conditions such as migraine, gastroenteritis or other psychologic and behavioral problems. In this episode, we discuss the classic signs and presentations of CNS tumors to support early detection. Our guest for today's episode is Dr. Green. Dr. Green is part of the Center for Cancer and Blood Disorders Team at Children's Hospital Colorado and is Assistant Professor of Pediatrics, Hematology/Oncology/and Bone Marrow Transplantation at the University of Colorado School of Medicine. Do you have thoughts about today's episode or suggestions for a future topic? Write to us, Chartingpediatrics@childrenscolorado.org
Mom Enough: Parenting tips, research-based advice + a few personal confessions!
Babies and young children are learning and doing new things every day. But parents often worry that their child's development isn't quite the same as the child next door. Or, perhaps they notice that their child's development seems slower in one area than another (walking early, for example, but not beginning to say words). There is a wide range of what's normal in early childhood, and it's not unusual for a child to develop at different rates in different domains. Nonetheless, it's a good idea to check out concerns. The good news is that there are free resources to help you know if your child's development is on track. These resources include online, research-based information about developmental milestones, as well as early childhood screening (free for any young child). If screening identifies a possible problem and further assessment shows that your child qualifies, free early intervention services are available. These supports are tailored to your child's needs and your preferences (with services available, for example, in your home or even online). In this episode of Mom Enough, Anna Paulson, Program Coordinator for Help Me Grow Minnesota, brings a wealth of information and practical ideas for how you can understand and support your child's optimal development. And she makes a strong case for how early intervention can make a lifelong difference for a child's learning and development. IS YOUR CHILD'S DEVELOPMENT ON TRACK? Visit the Help Me Grow website and take a look at the information and videos on developmental milestones for a child the age of yours. What does this suggest about how your child is learning and developing in different areas (motor, language, cognitive, social-emotional)? What ideas did you get from guest Anna Paulson about how to support your child's development at home? IS YOUR CHILD MEETING THEIR DEVELOPMENTAL MILESTONES? ❉ Help Me Grow. Check out Help Me Grow MN for information on developmental milestones, encouraging healthy development, and getting help if you have concerns about a child's development. You can also find Help Me Grow on Facebook and Instagram (developmental videos). ❉ CDC on Developmental Milestones. Check out the Centers for Disease Control and Prevention's resources on child development. Track your child's development and get a downloadable PDF with developmental information by age. You can also learn about the Milestone Tracker app for monitoring your child's development. ❉ Minnesota Learn the Signs Act Early. Minnesota Act Early is an outreach campaign that promotes early screening and identification of potential developmental delays. Get information on healthy development, early signs of Autism Spectrum Disorder (ASD) and other developmental delays, and early intervention options.
Clinical utilisation of the Infant Monitor of vocal Production (IMP) for early identification of communication impairment in young infants at-risk of cerebral palsy: a prospective cohort studyR Ward, N Hennessey, E Barty, C Elliott, J Valentine & R Cantle MooreABSTRACTAim: To report prospective longitudinal data of early vocalisations of infants identified “at-risk” of cerebral palsy (CP) for early identification of communication impairment.Method: This case-control longitudinal prospective cohort study reports on the assessment of 36 infants, 18 identified as at-risk of CP at the time of enrolment and 18 typically developing (TD) children, at three time points: 6 months, 9 months and 12 months of age, Data were obtained through criterion and norm referenced assessments of vocalisation behaviours.Results: Early vocal behaviours of infants identified as at-risk of CP did not differ from their age matched peers at 6 months of age, however, significant group differences emerged at 9 and 12 months when pre-canonical and canonical babble typically emerge. Generalised linear mixed models analysis showed that the rate of development of early language ability and more complex speech-related vocal behaviours was slower for infants at risk of CP when compared to TD infants, with over 75% of infants with CP showing below normal vocal production and impaired language by 12 months of age.Interpretation: Our data suggest characteristics of infant vocalisations associated with pre-canonical and canonical babbling provide a strong evidence base for predicting communication outcomes in infants at risk of CP.https://doi.org/10.1080/17518423.2021.1942280
Roberto and Smeeta are joined Michael G. Shlipak, MD from the University of California San Francisco and Sri Lekha Tummalapalli, MD, MBA from Weill Cornell Medicine to discuss their representation at the KDIGO Controversies Conference and its resulting ISN-KDIGO Chronic Kidney Disease (CKD) Early Identification and Intervention Toolkit, which offers a series of tools for CKD early identification and intervention aimed at kidney health professionals, primary care physicians and nurses working in primary care settings. Dr. Tummalapali and Shlipak discuss current screening recommendations, testing, treatments and how can nephrologists and other specialities prevent CKD and delay complications for those with early CKD.Learn more at: https://www.theisn.org/initiatives/ckd-early-screening-intervention/
Sow lameness continues to trouble hog operations in the US, causing high numbers of involuntary removals from herds. The post Early identification critical in preventing sow lameness appeared first on Pig Health Today.
Sow lameness continues to trouble hog operations in the US, causing high numbers of involuntary removals from herds. The post Early identification critical in preventing sow lameness appeared first on Pig Health Today.
Let Their Feet Lead the Way: Tools for Early Identification of FOP
Let Their Feet Lead the Way: Tools for Early Identification of FOP
Sow lameness continues to trouble hog operations in the US, causing high numbers of involuntary removals from herds. These expensive sow removals can be reduced by identifying lameness issues early and addressing equipment hazards that lead to sow injuries, reported Michael Pierdon, VMD, Four Star Veterinary Service, Elizabethtown, Pennsylvania.
Listen in as we discuss early identification and treatment of hearing loss in infants and toddlers. Sydney lists signs and symptoms to look for in infants and toddlers that could indicate possible hearing loss and how to advocate for your child if you have concerns about your child's hearing. Sydney shares when hearing first develops (it's sooner than you think!) and why and what to do if baby fails the initial hearing screenings. We talk about early amplification options and the recommended ages baby can access them along with the impact too many ear infections may have on hearing. This podcast episode if full of information great for parents of littles but also professionals in the field to stay abreast of what to look for and educate families on when it comes to hearing.
Literacy, a fundamental human right, is foundational for a child’s potential toward academic and lifelong success. For children with language-based learning disabilities such as dyslexia, mastering skilled reading can feel like an impossible endeavor without necessary support and teaching using proven instructional methods. Fortunately, there are powerful research-based antidotes toward potentially preventing a destiny of reading failure. In this episode, Hugh Catts, PhD explains why early screening and proven, effective reading intervention are critical to mitigating reading disabilities in children. He outlines the research supporting the current model, developed with Yaacov Petscher, PhD, which examines the factors that increase the probability of developing dyslexia. Being able to identify these factors is important to better understand how to effectively screen and provide more comprehensive support for all students, offering implications for research, policy, and education.Bookmarks and Resources:Do you want to learn more from this episode? Visit readpodcast.org and the Episode #18 homepage for host Danielle Scorrano's top bookmarks and resources. Do you have questions for future topics and speakers? E-mail us at info@readpodcast.org Connect with The Windward Institute on Twitter @TheWindwardInst, Instagram @thewindwardinstitute or Facebook.
Let Their Feet Lead the Way: Tools for Early Identification of FOP
Let Their Feet Lead the Way: Tools for Early Identification of FOP
Experts discuss tools to measure growth in infants, common causes of growth failure, and management recommendations. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/945150?src=mkm_podcast_addon_945150
Session 6 from the 2020 WSC Spotlight. Featuring Konrad Reinhart, Shally Awasthi, Arjen Dondorp, Rana Sharara-Chami, and Abdulelah Al-Hawsawi, with closing remarks from Edward Kelley and Niranjan ’Tex’ Kissoon, chaired by Ron Daniels. More info: wscspotlight.org
Every intimate garment does not fit every woman, especially after breast cancer. Dana Donofree experienced this first-hand. She started her entrepreneurial journey to not only design a beautiful bra that fit her but to empower other women to find confidence in their body and feel sexy after living with breast cancer. About Dana Dana is young, vibrant, energetic, and empowering women daily. Her journey is not the typical experience you would expect for a 37-year-old. She always had an entrepreneurial spirit, but it wasn't until she was diagnosed with breast cancer at the age of 27 that her current journey presented itself. Dana's journey will inspire you to be your own healthcare advocate, start facing your fears, and take action. She will enlighten you on breast cancer awareness and action you need to take to be your own advocate. Talking about Breast Cancer and The Changes Women Experience After Dana had reconstructive surgery 10 years ago, she couldn't find a bra that fit and quickly discovered that there were very few young women that she could ask for advice or support. She finally found a middle-aged breast cancer survivor who gave her the opportunity to begin having the much-needed conversations. It was through these conversations that Dana learned that options were limited and she wasn't the only woman struggling to find comfort and feel sexy again. Not only did Dana begin creating beautiful intimates for herself and other women with breast cancer, but she also opened the door for difficult conversations and has been empowering other women since. Ana Ono Dana's brand began as a mission to create comfortable bras that didn't have underwire or molded cups. Traditional bras do not fit post-mastectomy. She quickly realized that the world needed bra options for many other reasons such as open-heart surgery, shoulder surgery, and even young girls whose breasts are developing at different rates. Ana Ono now provides the options that women around the world need to feel comfortable, confident, and sexy in their own skin. The Entrepreneurial Journey Dana's journey as an entrepreneur started when she was very young. She is a fashion designer and always had the goal of having her own clothing line. Dana recommends that if you have dreams and goals, you should live life the way they want to, push fear aside, and do what you want to do. Don't wait until there is a life event to push you into doing what you dream of because time is running out. If you have an idea, don't stop before you start. There is a way to find financing and make your dream come to life. Breast Cancer Awareness and Action Although great strides have been made for breast cancer awareness and treatment, there is much work that needs to be done. We now need more action than awareness. We know breast cancer exists. It is the second leading cause of death in women. Awareness is no longer the issue. One in eight women is diagnosed with breast cancer. Over 40,000 people are being buried each year because of the disease. Men get breast cancer too. Breast cancer is a real threat to lives and it is truly an epidemic. Years of life have been lost focusing on awareness versus taking action to create new and better treatments. The increase in awareness has helped with earlier diagnosis. However, since the advent of COVID, breast cancer diagnoses are down 50%. That doesn't mean that the incidence has gone down, it means that people aren't going to the doctor and aren't getting mammograms. If people aren't getting diagnosed, the disease will be more advanced upon diagnosis, and there will be less time for treatment. Research Funding for Breast Cancer Treatment Billions of dollars have been raised because of the pink ribbons we see on products, but chances are that the money raised is not funding the necessary research for treatment. The money is funding awareness. But it's research that saves lives. Of funds raised, only two to three percent goes towards research for the treatment of metastatic stage 4 breast cancer. Stage 4 metastatic breast cancer is the only breast cancer that kills. Early diagnosis doesn't mean you survive. People with an early breast cancer diagnosis have a one in three chance of advancing to metastatic disease. Breast cancer is not cured. Organizations that Fund Research Metavivor is an organization that puts 100% of donations towards cancer research. Larger organizations have so much power, but they aren't using the funding for research. It's a disadvantage because, without the research, there is no advancement in treatment or a cure. The median life span of stage 4 metastatic breast cancer is 36 months. That is not a stat we should accept and do nothing about. Three Pillars of Supporting Breast Cancer Patients There are three areas of support needed for patients with breast cancer. The three areas are: Funding Support for Research Emotional support for patients Financial support for patients Living Beyond Breast Cancer is one such organization in the Philadelphia area that provides the aforementioned support for breast cancer patients. Many communities have local organizations that provide similar services and support. Early Identification of Breast Cancer It is important to note that mammograms are not perfect identification tools. Only 7 to 10 percent of breast cancer diagnoses are made from the results of mammograms. This statistic is not based on patients who found a lump first, these are stats for patients having a routine screening. Note that you are your best detection tool. Mark your calendar for the same day every month so that your breasts will feel the same based on your cycle. If you feel a change, such as a lump, skin irritation, discharge from the nipple, itching, or heat, call your doctor. Should your doctor dismiss your concern, do not take the answer “it's nothing”. Follow your gut and push for answers. Be your own advocate. See another doctor and ask for a scan, an ultrasound, and/or a mammogram. Do not take no for an answer and be your own advocate. You must fight for yourself to ensure you receive an early diagnosis. Learn more about your host, Robyn Graham, click HERE. To learn about The Brand Marketing Insider by Robyn Graham, click HERE. Join the Brand Marketing Insider Facebook Group HERE. Book a Brand Marketing Strategy Session HERE. Ask Me Anything HERE. Connect with me, Robyn Graham: Website | Instagram | LinkedIN | Facebook | Twitter | YouTube | Pinterest Learn more about and connect with Dana: Website: www.anaono.com Instagram: www.instagram.com/anaonointimates/ Facebook: https://www.facebook.com/anaonointimates Metavivor: https://www.metavivor.org Living Beyond Breast Cancer: https://www.lbbc.org
This week Bobbi Conner talks with Dr. Laura Carpenter about early identification of autism in young children and the interventions & therapy designed to help. Dr. Carpenter is a Professor of Pediatrics in the College of Medicine at MUSC.
The Filtrate:Matt SparksJoel TopfSwapnil HiremathJennie LinJordy CohenAnd two special guests:Morgan Grams, study author.Talar Kharadjian, nephrology fellow UC San DiegoShow Notes:History of albuminuria from Matt’s opening monolog: https://academic.oup.com/ndt/article/18/7/1281/1809803Microalbuminuria As A Predictor Of Clinical Nephropathy In Insulin-Dependent Diabetes Mellitus in the Lancet 1982.Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes in the NEJM 1984Episode of Freely Filtered with Dr. Feldman, the big guy at the top of the CRIC trial: NSAIDs vs Opioids.The Aldo study where they didn’t do a meta-analysis but they should have: Aldosteronism is everywhere.Estimating Urine Albumin-to-Creatinine Ratio from Protein-to-Creatinine Ratio: Development of Equations using Same-Day Measurements. Canadian data. CJASNThe kidney failure risk equation has a dotcom: https://kidneyfailurerisk.comKDIGO Controversies Conference on Early Identification & Intervention in CKDChoose Your Own Adventure: Cave of Time.Witte et al. in 2009 JASN on first morning urine vs 24 hour collection: First Morning Voids Are More Reliable Than Spot Urine Samples to Assess MicroalbuminuriaSensitivity and specificity for Joel to studyYour Manuscript On Peer ReviewNephrology Business Leaders University (NBLU)Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach with lead author Catherine Clasehttps://www.clothmasks.caElimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 (REPLACECOVID)Fast Grant. Apparently they are not just for Brian ByrdNephJC ACE2 Stuff as Jordy calls it: http://www.nephjc.com/news/covidace2The BRACE-CORONA trial a 700 person RCT of ACEi and ARB in Covid-19. No effect. Tweet stream by Swapnil.MC Hammer is a science nerd: https://cen.acs.org/education/science-communication/Hammer-time-Science-Twitter-drummers/98/i31Hammerman origin story for the MC Hammer cartoon.Bowman Society Lecture - Race & Renal Function CalculationsBasic Research Forum for Emerging Kidney Scientists: A Partnership Between APS and ASN
In this episode, Kate discusses the Center for Disease Control (CDC) Act Early Program. Kare is a state ambassador for the CDC for this initiative to learn the signs of possible developmental delay and how to get supports and resources for children and their families. Through this program there are also many valuable resources and materials for educators, caretakers and health professionals to use to raise awareness and gain knowledge. Kate Barlow, OTD is an Assistant Professor at American International College. She is also the current ambassador for the CDC’s Learn the Signs. Act Early. program for the state of Massachusetts. Dr. Barlow received her BS in Occupational Therapy from Boston University, and her MS and OTD from Virginia Commonwealth University. She has over 20 years of clinical experience that includes public school practice, early intervention, a pediatric hospital-based outpatient clinic and management. Dr. Barlow’s area of clinical expertise is pediatric feeding and swallowing, which she has presented on at the OT state conferences of CT, MA, NH and VA, as well as guest lectured on the topic at Western New England University, Shenandoah University and Virginia Commonwealth University. Dr. Barlow presented her research on pediatric feeding difficulties relating to ARFID at the World Federation of Occupational Therapy conference in South Africa. She is the current recipient of the Feeding Matters grant with Dr. Paula Rabaey for her current research in Pediatric Feeding Disorders. Dr. Barlow’s passion is in global outreach. She founded the International Interprofessional Mentorship Program that currently provides mentorship to over 100 therapists in over 15 countries. She also started an open educational resource (OER) page for occupational therapists to share resources and knowledge. https://libguides.aic.edu/OT_OER/webinars Additional Resources:CDC Learn the Signs. Act Early.Massachusetts Act Early (Many resources relevant for everyone)
In this episode I talk about the importance of early identification of young children with possible developmental delays. The key is knowing what to look for for each stage of development and what the next steps are to get more help and support. This identification can lead to early intervention and other therapies that can help not only children with possible autism but with any child with developmental delays.
Dr. Jan Hasbrouck describes the latest research on dyslexia, its early warning signs, and what families and educators can do to support success with structured literacy, multimodal experiences, and social-emotional support. Learn more at TeachersTalkShop.com.
Mom Enough: Parenting tips, research-based advice + a few personal confessions!
Identifying autism spectrum disorder at an earlier age is becoming easier. Although parents may fear having their child identified as having special needs, early identification and intervention greatly improve a child’s chances for lifelong success and wellbeing. Dr. Jennifer Hall-Lande, autism researcher at the University of Minnesota’s Institute of Community Integration, joins Marti & Erin to help parents understand the process of developmental screening, assessment and intervention. This show highlights the value of Help Me Grow as a source of information and support for parents of all young children. (A special thanks to Help Me Grow for supporting this important show and for being an ongoing partner of Mom Enough.) WHY IS EARLY SCREENING FOR AUTISM SPECTRUM DISORDER IMPORTANT? Why is a “wait and see” approach not a good idea for a child who is presenting signs of a possible autism spectrum disorder? What did you learn in this Mom Enough show about assessment and early intervention with children with ASD? WANT TO LEARN MORE ABOUT DEVELOPMENTAL MILESTONES? ❉ HELP ME GROW MINNESOTA. Explore resources on developmental milestones, encouraging healthy development, and how to get help for a child from Help Me Grow. ❉ LEARN THE SIGNS. ACT EARLY. Check out these helpful developmental milestone tracking tools from the CDC. ❉ MINNESOTA ACT EARLY. Minnesota Act Early reaches out to families, communities, and organizations to promote early screening and early identification of potential developmental delays. ❉ UNDERSTANDING THE EARLY SIGNS OF AUTISM SPECTRUM DISORDER: A CONVERSATION WITH DR. JED ELISON FROM THE UNIVERSITY OF MINNESOTA. Tune in to this important episode to learn more about early signs of autism spectrum disorder.
Cracking the Code for Fracture Risk: Improving the Early Identification of Patients
Cracking the Code for Fracture Risk: Improving the Early Identification of Patients
Cracking the Code for Fracture Risk: Improving the Early Identification of Patients
Cracking the Code for Fracture Risk: Improving the Early Identification of Patients
Episode 23 - SLI vs DLD, misconceptions about SLI, early identification of SLI, and the genetics of SLI with Mabel Rice
Early identification of colon cancer blood test places healthcare in patients hands
Katherine Wilemon and Kelly Myers join Christina Wayman from The Lancet Digital Health to discuss the potential of precision screening of individuals with familial hypercholesterolaemia.
How many of us have been in a clinical interview and wondered, “Could this be a thought disorder?” Sometimes it’s unclear which symptoms are worth concern and which ones are more typical. My guest today, Dr. Michelle Friedman-Yakoobian, has been conducting research and practice with psychotic disorders and prodromal states for nearly her entire academic career. We cover a lot ... Read More The post TTP #94: Dr. Michelle Friedman-Yakoobian – Early Identification of Psychosis appeared first on The Testing Psychologist.
We discuss with Jonathon discusses importance and challenges identifying themes and companies. What stages happen before a company is listed on the ASX, the role of corporate advisers and the current state of the market.https://www.prenzlergroup.com.au/
Episode 5: SLPs role in early identification of autism, parents' social skills, & clinical practice research with Megan Roberts
*In this episode we mention a Free Development Screening - details listed below. Date/Time: Saturday, Feb 9th, 9am to 12pm Location: AST Learning Center - West Loop, 670 W. Hubbard St., suite 200, Chicago, IL 60654 RSVP or get more information at 312.635.8989 or email angelina.guzman@autismtherapies.com Sharief Taraman, M.D. is Chief of General Neurology and of the CHOC Children’s Specialists Pediatric Subspecialty Faculty Pediatric Neurology Division. Dr. Taraman is also Chief Medical Officer at Cognoa, Inc., a digital behavioral health company and Health Sciences Assistant Clinical Professor at UC Irvine School of Medicine. He is board certified in Neurology with special qualifications in child neurology from the American Board of Psychiatry and Neurology and in Clinical Informatics from the American Board of Preventive Medicine. Taraman is a graduate of University of Michigan and Wayne State University. As one of CHOC Children’s Medical Informaticists, he develops and implements technology to improve healthcare delivery and outcomes and is actively involved in CHOC Children’s Medical Intelligence and Innovation Institute. All Autism Talk (allautismtalk.com) is sponsored by Autism Spectrum Therapies (AST) (autismtherapies.com), LEARN Behavioral (learnbehavioral.com) and the LEARN Provider Network.
Mom Enough: Parenting tips, research-based advice + a few personal confessions!
In the early months of life, a child grows and learns by leaps and bounds, making sense of language, emotions, social interactions and countless other aspects of the world around them. Between six months and one year there is a particular burst of development that is a veritable “social revolution.” But, as groundbreaking research is showing, children later diagnosed with autism spectrum disorder (ASD) show observable differences from their typically developing peers by one year of age. Yet far too often these children don’t receive intervention until years later. Professor Jed Elison from the U of M’s Institute of Child Development is one of the researchers leading the charge to improve the lives of children with ASD through early identification of autism and early intervention. In this week’s Mom Enough show, he calls us all to become informed, advocate for services and reduce the stigma of ASD. What new information did you hear in this Mom Enough discussion about early identification of autism? If signs of ASD are observable as early as 12 months, why do you think the average age at which Minnesota children with ASD get service is 4.9 years? What can you do to help change that? For the Elison Lab, click here. For autism resources, click here.
When should you stop CPR and pronounce death? Jordan MR, O’keefe MF, Weiss D, Cubberley CW, Maclean CD, Wolfson DL. Implementation of the universal BLS termination of resuscitation rule in a rural EMS system. Resuscitation. 2017;118:75-81. Jabre P, Bougouin W, Dumas F, et al. Early Identification of Patients With Out-of-Hospital Cardiac Arrest With No Chance […]
Reovirus is mutating every 2 to 3 years, which is making it difficult to protect broilers from the effects of the virus, Don Waldrip, DVM, technical service veterinarian for Zoetis, told Poultry Health Today.
Episode 12: Sepsis with Dr. Bernardo Reyes Fernandez / Coming Soon! Bernardo Reyes, MD., is a board-certified internist and geriatrician, he serves as Assistant Director of the Internal Medicine Residency Program and Associate Director of the Geriatric and Palliative Rotations and Assistant Professor of Clinical Biomedical Science in the Charles E. Schmidt College of Medicine at Florida Atlantic University (FAU). References: Fernandez, "Early Identification and Management of Sepsis", JAMDA, June 2018 Sloane, P, et al, “Can sepsis be detected in the Nursing Home Prior to the Need for Hospital Transfer?”, JAMDA, June, 2018 Dantes R and Epstein L, “Combatting Sepsis: A Public Health Perspective”, Clinical Infectious Diseases, May, 2018
Familial hypercholesterolaemia (FH) is a common inherited condition but most cases remain undiagnosed. The disease causes abnormally high levels of cholesterol in the blood and dramatically increases a person's risk of heart attack. In this episode, we speak to Steve Humphries, Professor of cardiovascular genetics at UCL and Professor Jane Armitage, a lipid expert from the University of Oxford. Mark Fisher has now traced the condition through several generations of his family and explains how early identification and statins have saved his children's lives. Read the full guidance on our website here: https://www.nice.org.uk/guidance/cg71
This week I spoke with Elham Shaabani and Paulo Shakarian (@PauloShakASU) about their recent paper Early Identification of Violent Criminal Gang Members (also available onarXiv). In this paper, they use social network analysis techniques and machine learning to provide early detection of known criminal offenders who are in a high risk group for committing violent crimes in the future. Their techniques outperform existing techniques used by the police. Elham and Paulo are part of the Cyber-Socio Intelligent Systems (CySIS) Lab.
Sandra Fortuin's presentation on ECD Early Identification in PDF format for downloading and browsing
CARTA - Center for Academic Research and Training in Anthropogeny (Video)
This lecture demonstrates how early screening at the 1st birthday can positively impact the search for biomarkers and lead to new discoveries regarding the study and treatment of autism. Karen Pierce (UC San Diego) emphasizes patterns of eye gaze as a potent early marker of autism and considers how fMRI can be used to examine neural functional organization in response to language in ASD toddlers. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Science] [Show ID: 24821]
CARTA - Center for Academic Research and Training in Anthropogeny (Audio)
This lecture demonstrates how early screening at the 1st birthday can positively impact the search for biomarkers and lead to new discoveries regarding the study and treatment of autism. Karen Pierce (UC San Diego) emphasizes patterns of eye gaze as a potent early marker of autism and considers how fMRI can be used to examine neural functional organization in response to language in ASD toddlers. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Science] [Show ID: 24821]
CARTA - Center for Academic Research and Training in Anthropogeny (Audio)
This fascinating and important series from CARTA explores the newest understandings of the roots of autism disorders from the foremost researchers in the world. In this episode, Karen Pierce and V.S. Ramachandran of UC San Diego are joined by UCLA’s Mirella Dapretto as they discuss The Early Identification of Autism, Mirroring in the Neurotypical and Autistic Brain, and Mirror Neuron Dysfunction in Neurology. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Science] [Show ID: 24455]
CARTA - Center for Academic Research and Training in Anthropogeny (Video)
This fascinating and important series from CARTA explores the newest understandings of the roots of autism disorders from the foremost researchers in the world. In this episode, Karen Pierce and V.S. Ramachandran of UC San Diego are joined by UCLA’s Mirella Dapretto as they discuss The Early Identification of Autism, Mirroring in the Neurotypical and Autistic Brain, and Mirror Neuron Dysfunction in Neurology. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Science] [Show ID: 24455]
2012/05/22. Educates parents, people living with autism, and the public about new findings in autism. Licensed psychologist and research assistant professor at the University of Washington.
2012/05/22. Educates parents, people living with autism, and the public about new findings in autism. Licensed psychologist and research assistant professor at the University of Washington.
DLS Lecture from 8 June 2011.
DLS Lecture from 18 May 2011.
DLS Lecture from 12 January 2011.
DLS Lecture from 13 April 2011.
DLS Lecture from 9 March 2011.
DLS Lecture from 8 December 2010.
Guidelines for implementing developmental surveillance and screening, using parent report and developmental screen measures.
Guest: Margaret Bauman, MD Host: Bill Rutenberg, MD Dr. Bauman discusses the spectrum of autism disorders and early identification of autism in children.
Remarkably elevated levels of phospholipase A(2) (PLA(2)) are measurable in human blood samples in cases of acute pancreatitis. The source of the enzyme was first thought to be exclusively the pancreas, but now it is generally accepted that two isoenzymes the pancreatic PLA(2), group I, and the extrapancreatic PLA(2), group II contribute to the raised activity. In contrast to the group II-PLA(2), the pancreatic PLA(2) is heatresistant for 1 hour at 60 degreesC. The catalytically inactive proenzyme of the pancreatic PLA(2) can be activated by trypsin. The aim of our study was to evaluate the diagnostic value of PLA(2) isoenzyme activity measurements to identify patients with severe complications in acute pancreatitis. Blood samples from patients suffering from acute pancreatitis were analyzed for catalytically active pancreatic PLA(2) on day 1 and 2 of hospitalization with a modified radiometric Escherichia colibased PLA(2) assay. In 10 of 41 patients clearly elevated values of catalytically active, heatresistant pancreatic PLA(2) (7.2 to 81.2 U/l) were observed. This group of patients was characterized by severe complications (necrotizing pancreatitis, shock, sepsis, respiratory problems) of which two patients subsequently died. Patients with low or undetectable activity (
Let Their Feet Lead the Way: Tools for Early Identification of FOP
Let Their Feet Lead the Way: Tools for Early Identification of FOP
Let Their Feet Lead the Way: Tools for Early Identification of FOP
Let Their Feet Lead the Way: Tools for Early Identification of FOP
© 2020-2025 Ivy Podcast Discovery LLC
